In vitro and in vivo characterisation of [3H]ANSTO-14 binding to the σ1 binding sites

Nuclear Medicine and Biology

Volumn 26, Issue 2, 1999, Pages 209-215

  Nguyen, Vu H ^a,b   Mardon, Karine ^b   Kassiou, Michael ^c   Christie, MacDonald J ^a  

^a University of Sydney   (Australia)

^b AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

; ANSTO 14; Binding sites; Biodistribution; Metabolite; Trishomocubanes

Indexed keywords

N (4 PHENYLBUTYL) 3 HYDROXY 4 AZAHEXACYCLO[5.4.1]DODECANE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; BRAIN MAPPING; CONTROLLED STUDY; DIENCEPHALON; DRUG SYNTHESIS; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABELING INDEX; LIGAND BINDING; NONHUMAN; RECEPTOR AFFINITY; RECEPTOR BINDING; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; BRIDGED COMPOUNDS; FEMALE; GUINEA PIGS; KINETICS; MALE; MOLECULAR STRUCTURE; ORGAN SPECIFICITY; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; TISSUE DISTRIBUTION;

EID: 0033019827     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00095-X     Document Type: Article

References (26)

1. Bennett J.P., Yamamura H.I. Neurotransmitter, hormone or drug receptor binding models. Yamamura H.I., Enna S.J., Kuhar M.J. Neurotransmitter Receptor Binding. 1985;61-89 Raven Press, New York.
2. 3) receptor subtype. Med. Chem. Res. 4:1994;225-237.
3. Booth R.G., Wyrick S.D., Baldessarini R.J., Kula N.S., Myers A.M. New σ-like receptor recognized by novel phenylaminotetralins Ligand binding and functional studies . Mol. Pharmacol. 44:1993;1232-1239.
4. Bowen W.D., Vilner B.J., Lee K.S., He X.-S., De Costa B.R., Weinberger D.R. A haloperidol-insensitive binding site for sigma-active aryl ethylene diamine-related compounds A novel sigma receptor subtype? Soc. Neurosci. Abstr. 21:1995;526.
5. Bylund D.B., Yamamura H.I. Methods for receptor binding. Yamamura H.I., Enna S.J., Kuhar M.J. Methods in Neurotransmitter Receptor Analysis. 1990;1-35 Raven Press, New York.
6. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
7. De Blasi A., O'Reilly K., Motulsky H.J. Calculating receptor number from binding experiments using same compounds as radioligand and competitor. Trends Pharmacol. Sci. 10:1989;227-229.
8. 3H](+)-pentazocine-defined σ recognition sites by phenytoin. Life Sci. 53:1993;41-48.
9. 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding. Nucl. Med. Biol. 23:1996;2201-2209.
10. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine. J. Neurosci. 6:1986;1757-1770.
11. John C.S., Bowen W.D., Varma V.M., McAfee J.G., Moody T.W. Sigma receptors are expressed in human non-small cell lung carcinoma. Life Sci. 56:1995;2385-2392.
12. Kassiou M., Nguyen V.H., Knott R., Christie M.J., Hambley T.W. Trishomocubanes, a new class of selective and high affinity ligands for the sigma binding site. Biorg. Med. Chem. Lett. 6:1996;595-600.
13. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
14. McPherson G.A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Programs Biomed. 17:1983;107-114.
15. McPherson G. A. (1987) KINETIC, EBDA, LIGAND, LOWRY: A collection of radioligand binding analysis programs. Elsevier-BIOSOFT, Cambridge, UK.
16. Munson P.J., Rodbard D. LIGAND A versatile computerized approach for characterization of ligand-binding systems . Anal. Biochem. 107:1980;220-239.
17. 3 receptor. J. Med. Chem. 37:1994;4109-4117.
18. 2 binding sites in rat and guinea pig brain membranes Novel subtype-selective trishomocubanes . Eur. J. Pharmacol. 311:1996;233-240.
19. Rodbard D. (1984) Lessons from the computerization of radioimmunoassays: An introduction to basis principles of modelling. In: Computers in Endocrinology (Edited by Rodbard D. and Forti G.), Vol. 14, pp. 75-99. Raven Press, New York.
20. 3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain Evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by σ ligands . Mol. Pharmacol. 39:1991;222-232.
21. 3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain . J. Pharmacol. Exp. Ther. 223:1982;284-290.
22. Su T., Schell S.E., Ford-Rice F.Y., London E.D. Correlation of inhibitory potencies of putative antagonists for σ receptors in brain and spleen. Eur. J. Pharmacol. 148:1988;467-470.
23. Tam S.W. Naloxone-inaccessible σ receptor in rat central nervous system. Proc. Natl. Acad. Sci. U.S.A. 80:1983;6703-6707.
24. Taylor J.E., Keyes S.R. Identification and characterization of s recognition sites on established tumors and tumor cell lines. Soc. Neurosci. Abstr. 18:1992;455.
25. 3 receptor Further structure-activity relationships . J. Med. Chem. 38:1995;3857-3864.
26. Wyrick S.D., Booth R.G., Myers A.M., Owens C.E., Kula N.S., Baldessarini R.J., McPhail A.T., Mailman R.B. Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity. J. Med. Chem. 36:1993;2542-2555.